PALB2 and cancer: Heterozygous mutations in PALB2 have been linked to a higher risk of breast [72,73] and pancreatic cancer [74], while homozygous mutations cause Fanconi anemia, a rare genetic disorder characterized by genomic instability and increased cancer risk [75,76].